Academia Sinica, Taiwan, invites applications and nominations for the position of Director of the Institute of Biomedical Sciences (IBMS). The initial appointment is for a period of three years and is renewable for a second term.
As the preeminent academic research institute in Taiwan, Academia Sinica is devoted to basic and applied research in mathematics, physical sciences, life sciences, social sciences and the humanities. Established in 1980s, the IBMS has become a world-renowned biomedical research institution in Taiwan. The 43 full time faculty are engaged in high impact basic and translational research that addresses global and local biomedical needs. Current research efforts of the IBMS cover 4 broad disease areas: Neuroscience, Cardiovascular & Metabolic Diseases, Infectious Disease & Immunology, and Cancer. The IBMS is well funded and equipped with state-of-the-art research facilities. For details about Academia Sinica and IBMS, please consult the respective websites: https://www.sinica.edu.tw/en/ & https://www.ibms.sinica.edu.tw/
Interested candidates should have a PhD and/or MD degree, a distinguished record of academic scholarship, diverse experiences in university and professional service, and a plan to pursue high impact research. The successful candidate will be expected to build on the existing strengths of the institute, develop new research thrusts, promote biomedical sciences, and provide intellectual leadership in life science research in Taiwan. The salary and start-up package are highly competitive.
Applications and nominations including a cover letter listing at least three references (including names and affiliations), a complete curriculum vitae, and a brief summary (no more than two pages) highlighting past research accomplishments, leadership experiences, and vision for future growth and development of the IBMS, should be submitted electronically to the IBMS Director Search Committee (email@example.com). Candidates with diverse backgrounds are encouraged to apply. Fluency in Chinese is not required. Applications/nominations will be accepted through 11/30/2023, or until the position is filled.